ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,035.69
-1.57%
Dow Jones
37,815.92
-1.49%
US Dollar vs MXN
17.1449
0.77%
Brent Oil
85.895
-1.59%
Bitcoin
60,520.01
-5.20%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Rigel Pharmaceuticals Inc (RIGL)

  7. Rigel Pharmaceuticals Inc (RIGL) Noticias

RIGL Rigel Pharmaceuticals Inc

1.05
-0.02 (-1.87%)
Fuera de horario
Última actualización: 17:32:59
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Rigel Pharmaceuticals Inc RIGL NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.02 -1.87% 1.05 17:32:59
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.07 1.04 1.1096 1.05 1.07
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202407:05PRNUSRigel Announces Conference Call and Webcast to Report First..
10/4/202415:30PRNUSRigel Announces Inducement Grants under NASDAQ Listing Rule..
04/4/202407:05PRNUSRigel Announces Publication of Data on REZLIDHIA®..
12/3/202407:05PRNUSRigel Pharmaceuticals Announces Appointment of Lisa..
05/3/202415:10EDGAR2Form 8-K - Current report
05/3/202415:06EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202415:01PRNUSRigel Reports Fourth Quarter and Full Year 2023 Financial..
01/3/202418:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202418:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202418:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202418:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202407:05PRNUSRigel Announces Conference Call and Webcast to Report Fourth..
22/2/202407:00EDGAR2Form 8-K - Current report
22/2/202406:50PRNUSRigel Pharmaceuticals Acquires U.S. Rights to GAVRETO®
14/2/202413:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202419:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202419:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202419:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202408:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
25/1/202420:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202420:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202420:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202420:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202412:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/1/202407:30EDGAR2Form 8-K - Current report
08/1/202407:05PRNUSRigel Pharmaceuticals Provides Business Update
05/1/202415:30PRNUSRigel Announces Inducement Grants under NASDAQ Listing Rule..
04/1/202407:05PRNUSRigel Announces Collaboration with CONNECT to Conduct a..
03/1/202407:05PRNUSRigel to Present at the 42nd Annual J.P. Morgan Healthcare..
08/12/202307:05PRNUSRigel Pharmaceuticals and MD Anderson Announce Strategic..
30/11/202305:04EDGAR2Form 8-K - Current report
07/11/202315:16EDGAR2Form 8-K - Current report
07/11/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202315:01PRNUSRigel Reports Third Quarter 2023 Financial Results and..
06/11/202307:05PRNUSRigel to Present at the Jefferies London Healthcare..
02/11/202308:27PRNUSRigel Announces Poster Presentations at the 65th American..
31/10/202307:05PRNUSRigel Announces Conference Call and Webcast to Report Third..
11/10/202307:05PRNUSRigel Announces Presentation at the Upcoming IDWeek 2023
06/10/202315:30PRNUSRigel Announces Inducement Grants under NASDAQ Listing Rule..
20/9/202307:05PRNUSRigel to Present at the 2023 Cantor Global Healthcare..
30/8/202307:05PRNUSRigel to Participate in Upcoming September Investor..
01/8/202315:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
01/8/202315:15EDGAR2Form 8-K - Current report
01/8/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202315:01PRNUSRigel Reports Second Quarter 2023 Financial Results and..
25/7/202307:00PRNUSRigel Announces Conference Call and Webcast to Report Second..
12/7/202317:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202317:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202317:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202317:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
RIGL
Rigel Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados